Medipharm Labs Corp (LABS) — Long-term Investment Intensity

Latest as of September 2021: 0.2%

Medipharm Labs Corp (LABS) has a Long-term Investment Intensity of 0.2% as of September 2021. Long-term investments of CA$191.00K represent 0.2% of total assets of CA$118.20 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Medipharm Labs Corp (LABS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

CA$191.00K
CAD

Total Assets

CA$118.20 Million
CAD

Country

Canada
TO

Medipharm Labs Corp Long-term Investment Intensity (2017–2020)

This chart shows how Medipharm Labs Corp's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2020. As of September 2021, the intensity stands at 0.2%, reflecting long-term investments of CA$191.00K against total assets of CA$118.20 Million CAD. For the complete balance sheet picture, see how large is Medipharm Labs Corp's balance sheet.

Annual Long-term Investment Intensity for Medipharm Labs Corp (2017–2020)

The table below presents the year-by-year Long-term Investment Intensity for Medipharm Labs Corp from 2017 to 2020, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read LABS total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CAD) Total Assets Change (pp)
2020 0.2% CA$191.00K CA$118.23 Million ▲ +0.0 pp
2019 0.1% CA$189.00K CA$168.83 Million ▼ -0.1 pp
2018 0.2% CA$81.00K CA$42.73 Million ▼ -12.3 pp
2017 12.5% CA$50.00K CA$400.00K
pp = percentage points